ID

14001

Beschreibung

the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient; ODM derived from: https://clinicaltrials.gov/show/NCT01766375

Link

https://clinicaltrials.gov/show/NCT01766375

Stichworte

  1. 21.03.16 21.03.16 -
Hochgeladen am

21. März 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Myeloid Leukemia NCT01766375

Eligibility Acute Myeloid Leukemia NCT01766375

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
Age: 18~50
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
Received peripheral blood hematopoietic stem cell transplantation from siblings or unrelated allogeneic donors with identical matching of hla or 1 alleles mismatched.
Beschreibung

Peripheral Stem Cell Transplantation

Datentyp

boolean

Alias
UMLS CUI [1]
C0242602
Diagnosis: refer to 2011 edition of aml china guideline for the diagnosis and treatment and diagnosis standards of high-risk acute myeloid leukemia developed through literatures (see appendix b);
Beschreibung

Acute Erythroblastic Leukemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0023440
Under general condition, ecog score ≤ 1;
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Normal cardiac functions
Beschreibung

Cardiac function

Datentyp

boolean

Normal liver and renal function: blood bilirubin≤35 μ mol\/l, ast/alt lower than twice in the upper limit of normal value, serum creatinine≤ 150 μ mol\/l;
Beschreibung

Renal and Liver function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
Subjects have signed the informed consent form.
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
Severe uncontrolled infection before transplantation;
Beschreibung

Infection

Datentyp

boolean

Alias
UMLS CUI [1]
C3714514
With contraindications of idarubicin
Beschreibung

Idarubicin

Datentyp

boolean

Alias
UMLS CUI [1]
C0020789
Reached the maximum cumulative dose of anthracyclines, for instance, dnr≥ 450mg/m2, mitoxantrone≥140mg/m2, the total cumulative dose of idarubicin≥ 300mg/m2;
Beschreibung

Anthracycline Antibiotics

Datentyp

boolean

Alias
UMLS CUI [1]
C0003234
The other conditions that do not meet the inclusion criteria.
Beschreibung

Inclusion criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C2827031
Withdrawal criteria:
Beschreibung

Withdrawal

Datentyp

integer

Alias
UMLS CUI [1]
C2349954

Ähnliche Modelle

Eligibility Acute Myeloid Leukemia NCT01766375

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
Age: 18~50
boolean
C0001779 (UMLS CUI [1])
Peripheral Stem Cell Transplantation
Item
Received peripheral blood hematopoietic stem cell transplantation from siblings or unrelated allogeneic donors with identical matching of hla or 1 alleles mismatched.
boolean
C0242602 (UMLS CUI [1])
Acute Erythroblastic Leukemia
Item
Diagnosis: refer to 2011 edition of aml china guideline for the diagnosis and treatment and diagnosis standards of high-risk acute myeloid leukemia developed through literatures (see appendix b);
boolean
C0023440 (UMLS CUI [1])
ECOG performance status
Item
Under general condition, ecog score ≤ 1;
boolean
C1520224 (UMLS CUI [1])
Cardiac function
Item
Normal cardiac functions
boolean
Renal and Liver function
Item
Normal liver and renal function: blood bilirubin≤35 μ mol\/l, ast/alt lower than twice in the upper limit of normal value, serum creatinine≤ 150 μ mol\/l;
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Informed consent
Item
Subjects have signed the informed consent form.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Infection
Item
Severe uncontrolled infection before transplantation;
boolean
C3714514 (UMLS CUI [1])
Idarubicin
Item
With contraindications of idarubicin
boolean
C0020789 (UMLS CUI [1])
Anthracycline Antibiotics
Item
Reached the maximum cumulative dose of anthracyclines, for instance, dnr≥ 450mg/m2, mitoxantrone≥140mg/m2, the total cumulative dose of idarubicin≥ 300mg/m2;
boolean
C0003234 (UMLS CUI [1])
Inclusion criteria
Item
The other conditions that do not meet the inclusion criteria.
boolean
C2827031 (UMLS CUI [1])
Item
Withdrawal criteria:
integer
C2349954 (UMLS CUI [1])
Code List
Withdrawal criteria:
CL Item
Those do not meet the inclusion criteria or meet the exclusion criteria after reviewing (1)
C2827031 (UMLS CUI-1)
CL Item
Patient withdraws the informed consent form (2)
C0021430 (UMLS CUI-1)
CL Item
Patient violates the clinical study protocol (3)
C2348563 (UMLS CUI-1)
CL Item
Patient experiences severe adverse events that treatment has to be terminated (4)
C0877248 (UMLS CUI-1)
CL Item
Patient that considered no longer fit to complete clinical trials by researchers. (5)
C0525058 (UMLS CUI-1)

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video